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Abstract
Previous research in the psychology of language has found that first- and secondperson pronouns have different uses beyond simply referring to different subjects. Firstperson pronouns are thought to forge a stronger association between self-concept and
emotion (Meissener, 2008), while second-person pronouns are inherently self-distancing
(Park, Adyuk & Kross, 2015). The present study sought to apply this knowledge to selfreport questionnaires to determine whether pronoun usage influenced self-report scores of
anxiety sensitivity. Both the ASI-3 and a second-person revised version were given to
participants during prescreening, baseline, and post-anxiety-intervention measures and
assessed for differences. Prescreen analysis revealed that the revised ASI-3 produced
lower scores for anxiety sensitivity than the original ASI-3, keeping in line with predicted
results. Baseline and post-intervention analysis, however, showed lower instances of
statistical differences between the measures at different times. This study begins to
establish a relationship between the pronoun structure of questionnaires and self-report
ratings, though further study is needed.
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Introduction
According to the Centers for Disease Control (CDC), anxiety disorders account
for the highest percentage of diagnosed mental disorders, with a lifetime prevalence of
over 15 percent (CDC, 2013). These disorders have a wide range of impact, causing
severe physical, cognitive, and social disabilities. The constellation of anxiety disorders
includes the diagnoses: simple phobias (e.g. snake, spider), generalized anxiety disorder,
panic disorders, and social anxiety disorder. These disorders have a variety of symptoms
such as persistent - and often unnatural or unnecessary - worry, recurring thoughts or
rituals, panic attacks, and fear (American Psychiatric Association, 2013).
Anxiety disorders also have substantial economic impact. According to
Greenberg (1999), in 1998 the national annual cost of anxiety disorders totaled
approximately $63.1 billion, accounting for (in decreasing percentage order)
nonpsychiatric medical treatment, psychiatric treatment, pharmaceutical costs, workrelated problems, and mortality costs. This amount in 2015 would total over $91 billion
after adjusting for inflation using the data provided by the Bureau of Labor Statistics
(2015). While diagnostic and treatment procedures have improved over time, a large
portion of these costs - to individual well-being as well as national economic burden could be avoided with earlier diagnosis and more effective and stable treatment.
Concerning early diagnosis, anxiety sensitivity is a known risk factor for anxiety
disorders, according to the American Psychiatric Association (2013). Anxiety sensitivity
is often colloquially referred to as the “fear of fear”. This nonclinical definition proves to
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be rather accurate, as the true psychiatric definition is the fear of arousal symptoms and
the resulting anxiety experienced when these symptoms occur, often in anticipation of a
negative outcome (Schmidt, Lerew & Jackson, 1997). Anxiety sensitivity has previously
been viewed as a more unidimensional concept, with concern placed only on physical
associations, such as the belief that a racing heart meant one was about to suffer a heart
attack. However, it has been found that anxiety sensitivity manifests not only in physical
sensations, but also in the social and cognitive domains (Taylor, Zvolensky, Cox,
Deacon, Heimberg, Ledley & Cardenas, 2007). Social anxiety sensitivity might manifest
in the fear that others can notice an individual’s panic and will judge him or her harshly.
Cognitive anxiety sensitivity, however, comes in the form of expected negative mental
health outcomes, such as the belief that if one loses track of one’s thoughts, then one is
going insane or is having a mental breakdown (Schmidt, Capron, Raines & Allan, 2014).
There are a multitude of studies linking anxiety sensitivity to psychological disorders,
with specific emphasis placed on anxiety-related disorders. In a meta-analytic review
(Olatunji & Wolitzky-Taylor, 2009), it was found that anxiety sensitivity is significantly
higher in clinical anxiety patients when compared with the non-clinical population.
Further linking this fear to anxiety disorders is the discovery that anxiety sensitivity is not
as prevalent in patients with mood disorders such as depression as it is in patients with
anxiety disorders (Olatunji & Wolitzky-Taylor, 2009). Due to this linkage, the treatment
of anxiety sensitivity has become an area of high interest in the field of psychology.
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A vital aspect of treating anxiety sensitivity is accurately assessing the construct.
One of the most common measures is the Anxiety Sensitivity Index 3 (ASI-3). The
primary goal of the questionnaire is to measure anxiety sensitivity not as a unitary
construct but instead assess levels of physical, social, and cognitive anxiety sensitivity
separately (Taylor, 2007). This questionnaire has been reported to be both valid and
reliable, able to accurately assess each of the three domains of anxiety sensitivity (Taylor,
2007), though the phrasing of its questions may present issues not investigated until this
study.
The existing ASI-3 relies heavily on first-person pronoun usage, with all of its 18
questions containing some variant of the word “I” (Taylor, 2007). This is true of many
self-report questionnaires in existence, though using such phrasing may not result in the
most accurate measurements. The word “I” and all of its variants serve to name an
individual and set it apart from others, but in doing so, it places one’s self-concept closer
to one’s actions and emotions (Meissner, 2008). This closeness is often seen in depressed
individuals, as shown by the study by Rude, Gortner, and Pennebaker (2010), which
found that first-person pronoun usage, which the ASI-3 relies on, can change depending
on a person’s mental health. This was measured via an essay-writing exercise which
found that depressed and formerly-depressed individuals had significantly higher rates of
first-person pronoun usage - specifically “I” usage - especially in regards to negative selfevaluation (Rude, 2010).
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Whereas “I” promotes personalization and proximity to action and consequence,
second- and third-person pronouns promote self-distancing. This self-distancing, if done
properly, can have therapeutic effects as it allows individuals to view situations through
the eyes of another rather than through their own biases (Park, Ayduk & Kross, 2015). It
has been found that self-distancing can be used as a coping mechanism for anxiety and as
a way to deal with future stressors (Kross, Bruehlman-Senecal, Park, Burson, Dougherty,
Shablack & Ayduk, 2014). Such self-distancing has also been found to be effective in
reducing negative emotions concerning previous traumatic events through
depersonalization by allowing an individual to separate his or her self-identity from the
event and thus add a layer of objectivity to the event (Park, 2015).
Given these findings, the usage of first-person pronouns in self-report
questionnaires - especially ones concerning negative, stigmatized topics such as
depression and anxiety - may not be as effective as using second-person pronouns such as
“you” and may in fact cause over-reporting of negative traits. In the past, however,
studies examining the effects of pronoun usage have focused primarily on depressed
individuals (Rude, 2010; Park, 2015) and to my knowledge have ignored individuals high
in anxiety or anxiety sensitivity. Given the common comorbidity of anxiety and
depressive disorders (Axelson & Birmaher, 2001), it is important to consider the impact
pronoun usage can have in anxious individuals and questionnaires relating to anxiety.
The goal of this study, therefore, is to assess this claim and determine whether the usage
of first-person pronouns versus second-person pronouns makes a significant difference in

4

the measurement of anxiety sensitivity. In this study, the ASI-3 will be modified to
reflect this idea, with all first-person pronouns changed to their second-person variants.
All individuals will complete both versions of the ASI-3 and the differences in anxiety
sensitivity levels measured by the two questionnaires will be assessed. Based on the
previous work on self-distancing, it is hypothesized that the original first-person pronoun
ASI-3 will show higher rates of anxiety sensitivity than the modified second-person
pronoun ASI-3. It is also hypothesized that these differences will be retained after a brief
computerized anxiety sensitivity intervention and that the original ASI-3 will display a
more significant change in anxiety sensitivity than the revised version.

Methods
Participants
The SONA prescreen contained 287 individual participants, while the
baseline/post-CBM analysis contained 34, with some overlap between these two groups.
Participants in the prescreen group included 45 male and 242 female undergraduates,
ranging in age from 18 to 52 years (M = 21.48, SD = 5.494). Participants came from a
range of cultural backgrounds, including Caucasian/European-American (63.4%),
African-American (26.5%), Asian (3.1%), Multiracial (3.1%), Hispanic (1.7%),
American Indian (.3%), and other backgrounds (1.7%). Participants were at various
stages of their college education, with 33.4% in their freshman year, 20.9% sophomores,
17.4% juniors, and 28.2% seniors.
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Individuals who took place in the overall study showed similar demographic
characteristics, including 7 male and 27 female participants ranging from 18 to 26 years
of age (M = 19.38, SD = 1.741) with varying backgrounds (2.95% Hispanic, 67.65%
Caucasian, 20.6% African-American, 5.9% Asian, and 2.95% Other). Because
participants in the broader study occasionally included non-students, college
classification was not assessed.
Participants were originally screened through introductory questionnaires, and
individuals found to score 1.5 SD above the mean on the Anxiety Sensitivity Index 3
(ASI-3) were asked through e-mail to schedule an additional appointment. Individuals
currently taking benzodiazepine medications, as well as individuals under 18 years of
age, were excluded from the study. Those who participated in the larger in-lab study
were offered compensation for their time in the form of extra credit for psychology
courses or, in some cases, a $15 Amazon gift card, while those who only took the
prescreen measure were only given the extra credit option due to the smaller time
commitment.
Measures
It is important to note that measures listed below that are not the original or
revised versions of the ASI-3 are used in this study primarily as filler measures to distract
participants from the repetition of the measures.
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Anxiety Sensitivity Index (ASI-3). In order to gauge baseline measures of
anxiety sensitivity for individual patients, the Anxiety Sensitivity Index 3 was
administered at the onset of the study. The 18-question self-report questionnaire is a
modification on the revised version of the original Anxiety Sensitivity Index (ASI-R)
designed to be multidimensional in its measure of anxiety sensitivity. This questionnaire
has been shown to efficiently measure anxiety sensitivity not only in the physical realm,
but in social and cognitive areas as well. The questions are scored on a five-point scale
based on how well one identifies with the prompts, with answers ranging from “Very
Little” to “Very Much” (Taylor, 2007).
ASI-3 Revised (ASI-Y). This modified version of the ASI-3 was designed to test
the differences in question phrasing concerning pronoun usage. The original 18
questions developed by Taylor et al. were edited, with all occurrences of first-person
personal and possessive pronouns, such as “I,” “me,” and “my,” changed to their secondperson counterparts, such as “you” and “your”. The goal of this revision is to identify
whether pronoun usage makes a difference in how an individual rates oneself on negative
criteria (i.e. anxiety sensitivity) in a self-report questionnaire. The questions are still
scored on the same five-point scale ranging from “Very Little” to “Very Much” and no
terminology that would affect the multidimensionality of the questionnaire was changed
(Taylor, 2007).
Beck Anxiety Inventory (BAI). This questionnaire will be administered to
measure the severity of anxiety in the study participants. The questionnaire features 21
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questions designed to determine the severity of anxiety in individuals and has been
shown to be reliable and valid. The questions feature various symptoms of anxiety and
are scored on a four-point scale from “Not At All” to “Severely” in order to determine the
presence and severity of various symptoms of anxiety (Beck, Epstein, Brown & Steer,
1988).
Brief Fear of Negative Evaluation Scale (FNE). This questionnaire measures
individuals’ fear of negative evaluation by peers and other individuals. Each of the
twelve questions presents an aspect of this fear and asks the individual to rate their level
of discomfort with each aspect regardless of its presence in everyday life on a five-point
scale ranging from “Very Little” to “Very Much”. This is a slight modification from the
original which asks how characteristic each aspect is (Leary, 1983).
Treatment Conditions
The Active CBM-I condition consisted of a program designed through E-Prime
software, similar in content to the one developed by Beard and Amir in their study on
interpretation modification (Beard & Amir, 2008). The program displayed a word or
short phrase on the screen for one second, followed by a brief sentence with content that
could be related to the word. Approximately half of the word/sentence combinations
were benign in interpretation, and half were threatening or anxiety-related. Participants
were then prompted to respond whether the word and sentence are related or unrelated.
The goal of the program was to encourage benign interpretations of arousal symptoms
and discourage threat interpretations. To do this, a positive or “Correct” response was

8

given to a “related” answer for benign interpretations, and a negative or “Incorrect”
response was given to a “related” answer for threatening interpretations. “Incorrect”
answers were reinforced by a loud “beep”. Forty such trials were completed without
reinforcement of answers, forty with reinforcement, and forty unique trials were
completed following the previous eighty to measure changes in interpretive bias.
The participants in the control condition received a similar intervention as the one
received by the active condition, though in the control condition no threatening
interpretations were produced. Instead, the only sentences displayed were benign and
unrelated to anxiety disorders. This intervention was designed to impact anxiety
sensitivity as little as possible.
Procedure
Individuals were screened in advance through the introductory psychology mass
screening provided by USM at the beginning of each semester. Those participants that
were not chosen through the mass screening were screened through SONA or Qualtrics
surveys. Each survey measured anxiety sensitivity to provide a way to screen out
participants, though the SONA screening measure included both the original ASI-3 and
the ASI-Y, separated by additional measures such as the BAI, FNE, and ISI. This
separation was done keep participants unaware of the connection between the two
versions of the ASI, as well as to ensure that repetition of the measures did not confound
the study by causing significant rating changes independent of the pronoun changes. The
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SONA screening scores for both versions of the ASI were collected and assessed for
differences by running Wilcoxon signed-rank tests and paired T-tests through SPSS.
All eligible participants were asked to read and sign a consent form explaining the
study prior to moving forward with the study. They were also given contact information
for the researchers in case of any questions. They were then asked to provide basic
demographic information and complete a pre-intervention assessment including both
versions of the ASI, as well as several other self-report measures such as the BAI and the
FNE. As previously mentioned, individuals taking benzodiazepine medications, as well
as individuals under 18 years of age, were excluded from the study.
The study conducted for the purpose of this thesis took place within a larger study
concerning the use of cognitive bias modification for interpretive bias (CBM-I) for
anxiety sensitivity. Participants who continued to the broader study were randomly
placed in either the active or control CBM-I groups as previously described. The
respective interventions were administered to individual participants in private rooms.
Following the interventions, a battery of questionnaires identical to the pre-assessment
was administered, as well as the straw-breathing behavioral fear challenge. This
challenge required participants to breathe through a narrow straw to simulate feelings of
anxiety and panic in a low-risk environment. Follow-up measures were given online both
one week and one month following the completion of the interventions.
Following the study, the baseline and post-CBM assessments were analyzed for
AS differences between the two measures. Both versions of the ASI were also assessed
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for convergent validity against the BAI and for divergent validity against the FNE.
Correlation measures were run through SPSS, as well as Wilcoxon signed-rank tests and
paired T-tests.
Results
SONA Prescreen Analysis
To determine whether there was a significant difference between the original ASI3 and the ASI-Y, correlational analyses were run, as well as both parametric and
nonparametric comparison tests.
Both measures in the prescreen (n = 287) showed high correlations to the Beck
Anxiety Inventory, with a slightly higher correlation for the ASI-Y (r = .737) than the
original ASI-3 (r = .72). Lower, though still relatively high, correlations were found
between the measures and the Fear of Negative Evaluation Scale as well, with the ASI-Y
once again showing a marginally higher correlation (r = .647, compared to r = .641).
The measures themselves showed an extremely high – though imperfect – correlation
with each other (r = .920). For a full list of correlation coefficients, see Figure 1.
A Wilcoxon Signed Rank Test found a statistically significant difference in
medians between the two scores (z = -7.089, p < .001) and an effect size bordering the
recommendations between small and medium (r = 0.297), with the median score
decreasing by four points (Md = 20.0 to Md = 16.0) from the original to the revised
measures. Further analysis indicated approximately 84.64% shared variance between the
measures.
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Mean scores also shifted substantially between measures, as indicated by a pairedsamples t-test. Anxiety sensitivity mean scores from the original ASI-3 (M = 21.96, SD =
15.04) were higher than scores measured by the ASI-Y (M = 19.60, SD = 15.77), t (286)
= 6.442, p < .0005 (two-tailed), with a mean decrease of 2.36 at a 95% confidence
interval stretching from 1.64 to 3.08. A medium effect size was found between the
measures (eta squared = 0.13).
Baseline and Post-CBM Analysis
Results from both before and after the CBM-I intervention were recorded and
analyzed to expand upon the previously perceived difference between the two measures,
though these groups included a significantly smaller sample (n = 33). Additionally, in
some analyses, participant responses had to be excluded due to failure to fully complete
the measures. In the control condition (n = 14), only 13 had completely filled out the
baseline measure for the ASI-Y, though all other measures were fully recorded for each
participant. In the active condition (n = 19), only 18 completed the baseline measure of
the ASI-Y, as well as the post-CBM FNE and ASI-Y measures. Additionally, only 16
completed the post-CBM ASI-3 and 15 completed the post-CBM BAI.
Correlational analysis in the control group once again revealed strong correlations
between both versions of the ASI and the BAI taken at baseline, with somewhat higher
correlations for the ASI-Y (r = .738) than for the ASI-3 (r = .692), as well as for these
same measures taken post-intervention, with correlational values once again marginally
higher for the ASI-Y (r = .730) than for the ASI-3 (r = .684). In this analysis, however,
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the correlations between the two versions of the ASI and the FNE were moderate to low
at both baseline and post-intervention measures, and these values did not exceed the
threshold for statistical significance.
Compared against each other, the two versions of the ASI used in this study again
showed extremely high correlation with each other at the baseline measurement (r =
.934), with nearly identical scores at post-intervention measurement (r = .932). Pre-post
measures indicate nearly identical correlations between baseline and post-intervention
ASI-3 scores (r = .940) and those same measures taken by the ASI-Y (r = .938).
Correlations become more disparate when comparing the baseline ASI-3 to the postintervention ASI-Y scores (r = .886) and comparing the baseline ASI-Y to the postintervention ASI-3 scores (r = .991). For a more complete picture of control-group
correlations, see Figure 2.
Active-condition correlational analysis produced slightly different results. The
original ASI-3 once again showed high correlations to the BAI (r = .642), as did the ASIY (r = .658), and both versions of the ASI displayed very high correlation with each other
(r = .932), with these values rising slightly at the post-intervention measures (r = .983).
In this analysis, though, correlations were high and statistical significance was
reached when comparing the FNE to both the ASI-3 (r = .659) and ASI-Y (r = .616).
Correlations rose when comparing these same measures at post-intervention
measurement, with original ASI-3 scores displaying stronger post-treatment correlations
to the BAI (r = .861) and the FNE (r = 8.19) than the ASI-Y showed when compared
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against those measures (r = .745 and r = .785, respectively). This difference in scores
mimics the difference in the control group, though values for the control group – as stated
earlier – were not found to be statistically significant when comparing these measures.
Active condition pre-post analysis reveals high correlations between baseline and
post-intervention measures of both ASI versions in all directions, though these
correlations are, for the most part, weaker than their control-group counterparts. The
correlational values for pre- and post-intervention original ASI-3 scores (r = .807) were
weaker than those found for pre- and post-intervention ASI-Y scores (r = .884). In
addition, correlations between baseline ASI-3 and post-CBM ASI-Y scores (r = .755)
were weaker than correlations between baseline ASI-Y and post-CBM ASI-3 scores (r =
.914). For a full list of active condition correlation coefficients, see Figure 3.
A Wilcoxon signed rank test revealed information contrary to that presented by
the prescreen analysis. A statistically significant difference was found between baseline
ASI-3 and ASI-Y measures in the active condition (z = -1.969, p < .05) with a medium
effect size (r = .32) and median scores decreasing from Md = 39.0 (original) to Md = 34.5
(revised), though this difference was not observed in the control condition. In addition,
no significant differences between post-intervention ASI’s or baseline-to-postintervention measures were not found in this analysis.
A paired t-test brought forth similar results, with significant results found only for
active condition baseline anxiety sensitivity measures, with scores decreasing between
the ASI-3 (M = 38.83, SD = 13.44) and the ASI-Y (M = 34.72, SD = 18.17), t(17) =
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2.338, p <.05 (two-tailed). The mean decrease between measures was 4.11 at a 95%
confidence interval ranging from .40 to 6.56 and an eta squared (0.24) that indicated a
large effect.
In addition, the analysis found no significant difference in the rate of change from
baseline to post-intervention between the two anxiety sensitivity measures.

Discussion
Previous research on pronoun usage indicates that first-person pronouns
strengthen the link between self-concept and negative stimuli, especially when
concerning mental health (Meissener, 2008; Rude, Gortner & Pennebaker, 2010).
Second-person pronouns, on the other hand, are indicative of objectivity (Park, Adyuk &
Kross, 2015). While these relationships have been readily established, they have yet to
be applied to self-report questionnaires – a knowledge gap that this study sought to
address.
Based on the information provided by the prescreen analysis, it is reasonable to
assume there is a difference between the original ASI-3 and the ASI-Y. Correlations
were high between all measures, providing evidence that the ASI-Y is still valid, though
they strengthened slightly when comparing the BAI and the FNE to the ASI-Y as
opposed to comparison with the ASI-3. Both the mean and median scores for the two
anxiety sensitivity measures shifted downward between ASI-3 and the ASI-Y; one
possible explanation for this is the self-distancing theory discussed earlier (Park, Adyuk
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and Kross, 2015) acting in combination with the increased negative self-evaluation that
often accompanies first-person pronouns (Rude, Gortner & Pennebaker, 2010). In
general, participants tended to score slightly lower on the ASI-Y than on the ASI-3,
suggesting at least some confirmation of the primary hypothesis.
Baseline and post-intervention analysis, however, revealed some anomalies, only
indicating a statistically significant difference between the two measures in the active
condition, while baseline-to-post measures and control condition measures showed no
significance. In addition, correlations between the two measures and the FNE did not
reach statistical significance in the control group analysis, though they did in the active
group. One of the primary problems with this data set is the extremely small sample size,
due in part to both low participant recruitment rates and the lack of complete responses
from participants. Due to the varying significance values, the secondary hypothesis –
that the differences between the two anxiety sensitivity measures would be retained after
a brief intervention – cannot be confirmed at this time. The final hypothesis concerning
the rate of change in the measures from baseline to post-intervention was also voided.
This study had several limitations that should be addressed in future studies.
Primarily there is the issue of using undergraduate students, especially those receiving
compensation for their participation. Undergraduate samples are not necessarily
representative of the general public, and individuals responding to questionnaires for the
purpose of receiving compensation instead of out of earnest interest in the study may not
be as motivated to provide accurate information. In addition, self-report questionnaires
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are inherently flawed in that they rely on participant honesty and accurate self-assessment
rather than focusing on observable behaviors or other more concrete material.
Beyond these issues, the repetition of measures may have caused some response
bias, as participants may have sought to reproduce their answers from the first
assessment. Though prescreen results indicate that this may not have been the case,
future studies might benefit from using a between-groups method of analysis for the two
measures, rather than the within-groups method employed in this study.
Originally, the anxiety sensitivity measures were to be analyzed both one week
and one month following the in-lab intervention; however, due to time constraints and
low participant recruitment rates – potentially due to the length (1.5 hours) of the in-lab
portion of the study – these measures were not able to be obtained for inclusion in this
thesis. Future replications might consider employing these post-intervention measures in
order to see if the disparity between the two measures remains after such a length of time.
The present study does indicate at least a mild relationship between pronoun
usage and self-report anxiety sensitivity scores; however, further research is necessary in
order to establish a concrete link between the two concepts. By bridging this knowledge
gap in current psychometric literature, we can work to improve the accuracy of selfreport questionnaires and thus advance diagnostic capabilities.
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Appendix B: Consent Form
University of Southern Mississippi
Consent to Participate in a Research Study
______________________________________________________________________
Title of Study: Brief Computerized Stress Intervention for Anxiety
Principal Investigator: Daniel Capron, Ph.D.
USM Department: Psychology Department
Phone number: 601-266-4380
Study Contact email: Daniel.Capron@usm.edu
_________________________________________________________________
What are some general things you should know about research studies?
You are being asked to take part in a research study. To join the study is voluntary.
You may refuse to join, or you may withdraw your consent to be in the study, for any
reason, without penalty.
Research studies are designed to obtain new knowledge. This new information may help
people in the future. You may not receive any direct benefit from being in the research
study. There also may be risks to being in research studies.
Details about this study are discussed below. It is important that you understand this
information so that you can make an informed choice about being in this research study.
You should ask the researchers named above, or staff members who may assist them, any
questions you have about this study at any time.
What is the purpose of this study?
The purpose of this study is to evaluate different treatments designed to help people
reduce their anxiety sensitivity, the extent to which individuals believe symptoms of
anxiety are potentially harmful.
How long will your part in this study last?
The total time commitment for the current study will be about 1.5 to 2 hours.
The project consists of:
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1 visit to a lab that will take 1 - 1.5 hours
2 very brief follow-up online questionnaires expected to take 5-10 minutes

What will happen if you take part in the study?
The current research study will include the following:
 Lab visit
During this appointment you will be asked to complete a series of
questionnaires. Next, you will be randomly assigned to receive either an active
computer intervention that targets anxiety-related interpretations or a control
program designed to not have any effect on anxiety-related interpretations. This
appointment
will also entail breathing through a narrow straw. This activity may cause
you to experience some physical sensation akin to anxiety; however, the
sensations
are momentary and the procedure has been used safely in similar experiments for
over 10 years.
 Online Follow-ups
One week and one month after the experiment appointment you will be sent a link
to a secure website to fill out a very brief computer questionnaire.
What are the possible benefits from being in this study?
Research is designed to benefit society by gaining new knowledge. You may also expect
to benefit by participating in this study by receiving either a $15 gift card or up to 4.5
course credits for your Psychology course.
What are the possible risks or discomforts involved from being in this study?
The risks to human subjects in the proposed study are minimal. Nevertheless, precautions
will be taken to minimize any risks you may incur in the proposed study. Some
individuals may experience slight discomfort describing their thoughts. The strawbreathing challenge can also create a mild level of physical discomfort; however, any
discomfort you may experience is completely temporary and will be only momentary.
These situations should not be any more anxiety-provoking than situations commonly
experienced in day-to-day life. If it is determined that there is an immediate need for
assistance, you will be referred to clinicians with whom you may speak about your
discomfort or distress. You furthermore have the right to refuse or discontinue
participation at any time. There may be uncommon or previously unknown risks. You
should report any problems to a member of our research team.
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How will your privacy be protected?
Careful measures will be taken to ensure your confidentiality as a participant in this study
will be protected to the extent allowed by law. Each participant will be assigned an
Identification Code with which all questionnaires and behavioral observations will be
labeled. The key associating Identification Codes with participant names will be kept
separate from all assessment materials and consent forms in a secured file. You may
inquire about referral sources if you wish, and the experimenter will be able to provide
you with that information. All other questionnaire data relevant to this project will be
destroyed on or before December 31, 2026.
Will you receive anything for being in this study?
You will be receiving either a $15 gift card or 4.5 research credits total for the
Introduction to Psychology course. You will receive this credit for today’s appointment
plus your participation in the brief online one week and one month follow up computer
questionnaires.
Will it cost you anything to be in this study?
There will be no costs for being in the study.
What if you are a USM student?
You may choose not to be in the study or to stop being in the study before it is over at
any time. This will not affect your class standing or grades at USM. You will not be
offered or receive any special consideration if you take part in this research.
What if you have questions about this study?
You have the right to ask, and have answered, any questions you may have about this
research. If you have questions, or concerns, you should contact the researchers listed on
the first page of this form.

-------------------------------------------------------------Participant’s Agreement:
I have read the information provided above. I have asked all the questions I have at this
time. I voluntarily agree to participate in this research study.
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_________________________________________ _________________
Signature of Research Participant
Date
_________________________________________
Printed Name of Research Participant

If you would like to be contacted to participate in future research studies, please list
your email address:

____________________________________________________________________

This project and this consent form have been reviewed by the Institutional Review
Board of The University of Southern Mississippi, which ensures that research projects
involving human subjects follow federal guidelines. Any questions or concerns about
rights as a research participant should be directed to the Chair of the Institutional
Review Board, The University of Southern Mississippi, Box 5147, Hattiesburg, MS
39406, (601) 266-6820. A copy of this form will be given to you, the research
participant.
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Appendix C: ASI-3

INSTRUCTIONS: Circle the one phrase that best represents the extent to which you
agree with the item. If any of the items concern something that is not part of your
experience, answer on the basis of how you think you might feel if you had such an
experience. Otherwise, answer all items on the basis of your own experience.

1. It is important to me not to appear nervous.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

2.When I cannot keep my mind on a task, I worry that I might be going crazy.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

MUCH

VERY MUCH

3. It scares me when my heart beats rapidly.
VERY LITTLE

A LITTLE

SOME

4. When my stomach is upset, I worry that I might be seriously ill.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

5. It scares me when I am unable to keep my mind on a task.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

6. When I tremble in the presence of others, I fear what people might think of me.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

7. When my chest feels tight, I get scared that I won’t be able to breathe properly.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

8. When I feel pain in my chest, I worry that I’m having a heart attack.
VERY LITTLE

A LITTLE

SOME
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MUCH

VERY MUCH

9. I worry that other people will notice my anxiety.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

10. When I feel “spacey” or spaced out, I worry that I may be mentally ill.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

MUCH

VERY MUCH

11. It scares me when I blush in front of people.
VERY LITTLE

A LITTLE

SOME

12. When I notice my heart skipping a beat, I worry that there is something seriously
wrong with me.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

13. When I begin to sweat in social situations, I fear people will think negatively of me.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

14. When my thoughts seem to speed up, I worry that I might be going crazy.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

15. When my throat feels tight, I worry that I could choke to death.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

16. When I have trouble thinking clearly, I worry that there is something wrong with me.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

17. I think it would be horrible for me to faint in public.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

18. When my mind goes blank, I worry that there is something terribly wrong with me.
VERY LITTLE

A LITTLE

SOME
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MUCH

VERY MUCH

Appendix D: ASI-Y
INSTRUCTIONS: Circle the one phrase that best represents the extent to which you
agree with the item. If any of the items concern something that is not part of your
experience, answer on the basis of how you think you might feel if you had such an
experience. Otherwise, answer all items on the basis of your own experience.

1. It is important to you not to appear nervous.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

2. When you cannot keep your mind on a task, you worry that you might be going crazy.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

MUCH

VERY MUCH

3. It scares you when your heart beats rapidly.
VERY LITTLE

A LITTLE

SOME

4. When your stomach is upset, you worry that you might be seriously ill.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

5. It scares you when you are unable to keep your mind on a task.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

6. When you tremble in the presence of others, you fear what people might think of you.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

7. When your chest feels tight, you get scared that you won’t be able to breathe properly.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

8. When you feel pain in your chest, you worry that you’re having a heart attack.
VERY LITTLE

A LITTLE

SOME

MUCH

9. You worry that other people will notice your anxiety.
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VERY MUCH

VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

10. When you feel “spacey” or spaced out, you worry that you may be mentally ill.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

MUCH

VERY MUCH

11. It scares you when you blush in front of people.
VERY LITTLE

A LITTLE

SOME

12. When you notice your heart skipping a beat, you worry that there is something
seriously wrong with you.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

13. When you begin to sweat in social situations, you fear people will think negatively of
you.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

14. When your thoughts seem to speed up, you worry that you might be going crazy.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

15. When your throat feels tight, you worry that you could choke to death.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

16. When you have trouble thinking clearly, you worry that there is something wrong
with you.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

17. You think it would be horrible for you to faint in public.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

18. When your mind goes blank, you worry that there is something terribly wrong with
you.
VERY LITTLE

A LITTLE

SOME
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MUCH

VERY MUCH

Appendix E: FNE
Mark the appropriate answer corresponding to the one phrase that best represents the
extent to which you agree with the item. If any of the items concern something that is not
part of your experience, answer on the basis of how you think you might feel if you had
such an experience. Otherwise, answer all items on the basis of your own experience.

1. Sometimes I think I am too concerned with what other people think.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

2. I worry about what kind of impression I make on people.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

MUCH

VERY MUCH

3. I am afraid that people will find fault with me.
VERY LITTLE

A LITTLE

SOME

4. I am concerned about other people’s opinions of me.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

5. When I am talking to someone, I worry about what they may be thinking of me.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

MUCH

VERY MUCH

6. I am afraid that others will not approve of me.
VERY LITTLE

A LITTLE

SOME

7. I am usually worried about the kind of impression I make.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

8. I am frequently afraid of other people noticing my shortcomings.
VERY LITTLE

A LITTLE

SOME
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MUCH

VERY MUCH

9. I worry what other people will think of me when I know it doesn’t make any
difference.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

10. It bothers me when people form an unfavorable opinion of me.
VERY LITTLE

A LITTLE

SOME

MUCH

VERY MUCH

MUCH

VERY MUCH

11. I often worry that I will say or do the wrong things.
VERY LITTLE

A LITTLE

SOME

12. If I know that someone is judging me, it tends to bother me.
VERY LITTLE

A LITTLE

SOME
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MUCH

VERY MUCH

Appendix F: BAI
Below is a list of common symptoms of anxiety. Please carefully read each item in the
list. Indicate how much you have been bothered by each symptom during the PAST
WEEK, INCLUDING TODAY, by choosing the answer that best fits.
Not At
All

Mildly (It did
not bother me
much.)

1. Numbness or
tingling.
2. Feeling hot
3. Wobbliness in legs.
4. Unable to relax.
5. Fear of the worst
happening.
6. Dizzy or
lightheaded.
7. Heart pounding or
racing.
8. Unsteady.
9. Terrified.
10. Nervous.
11. Feelings of
choking.
12. Hands trembling.
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Moderately (It
was very
unpleasant, but
I could stand
it.)

Severely (I
could barely
stand it.)

13. Shaky.
14. Fear of losing
control.
15. Difficulty
breathing.
16. Fear of dying.
17. Scared
18. Indigestion or
discomfort in
abdomen.
19. Faint.
20. Face flushed.
21. Sweating (not due
to heat).
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Appendix G: Sample Word-Sentence Pairings

Control Related
Blank…………..….Nothing was written on the page.
Can’t focus……..…The camera couldn’t find a focal point.
Control Unrelated
Blank………………The leaves are green.
Can’t focus…………Seven is a number.
Active Benign
Blank……………….It is nice to take a break sometimes.
Can’t focus…………I should rest after such a long day.
Active Threatening
Blank……………….Something is wrong with my thoughts.
Can’t focus…………I think I am going insane.
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Appendix H: Tables
Table 1
Prescreen Correlations
Variables
1
1. Total ASI-3
2. Total BAI
.726**
3. Total FNE
.641**
4. Total ASI-Y
.920**
M
21.96
SD
15.04

2

3

4

.551**
.737**
16.15
13.11

.647**
22.50
14.42

19.60
15.78

**p<.01
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Table 2
Correlations Between Measures in Control Condition
Variables
1
2
3
4
1. Baseline ASI-3
2. Baseline BAI

.692**
n=14
3. Baseline FNE
.401
n=14
4. Baseline ASI-Y
.934**
n=13
5. Post-CBM ASI-3 .940**
n=14
6. Post-CBM BAI
.654*
n=14
7. Post-CBM FNE
.436
n=14
8. Post-CBM ASI-Y .886**
n=14
M
39.29
SD
14.23

5

6

7

8

.218
n=14
.738**
n=13
.650*
n=14
.903**
n=14
.190
n=14
.637*
n=14
27.21
13.09

.261
n=13
.355
n=14
.308
n=14
.777**
n=14
.489
n=14
30.43
18.40

*p<.05 **p<.01
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.991**
n=13
.793**
n=13
.308
n=13
.938**
n=13
39.15
15.38

.684**
n=14
.405
n=14
.932**
n=14
39.00
17.23

.189
n=14
.730**
n=14
22.14
15.17

.324
n=14
34.07
17.79

37.07
16.21

Table 3
Correlations Between Measures in Active Condition
Variables
1
2
3
4
1. Baseline ASI-3
2. Baseline BAI

.642**
n=19
3. Baseline FNE
.659**
n=19
4. Baseline ASI-Y
.932**
n=18
5. Post-CBM ASI-3 .807**
n=16
6. Post-CBM BAI
.830**
n=15
7. Post-CBM FNE
.668**
n=18
8. Post-CBM ASI-Y .755**
n=18
M
38.74
SD
13.06

5

6

7

8

.372
n=19
.658**
n=18
.639**
n=16
.872**
n=15
.558*
n=18
.545*
n=18
26.95
11.16

.616**
n=18
.719**
n=16
.631*
n=15
.908**
n=18
.663**
n=18
38.95
11.10

*p<.05 **p<.01
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.914**
n=16
.839**
n=14
.763**
n=17
.884**
n=17
34.72
18.17

.861**
n=13
.819**
n=16
.983**
n=16
35.06
19.91

.674**
n=15
.745**
n=15
22.73
12.36

.780** n=18
37.39 33.11
12.37 18.96

